Find and Pitch Jounalists, Get Your Story Covered

Tags: Paris breath bacterial endocarditis trauma nursing

	Profile	Recent Articles on Subject
1	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Personalizing Treatments and Patient Education - 6 days ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 20 days ago Real-World Considerations for New Therapies - 27 days ago Impact of Transplant Eligibility on Treatment Selection - about 1 month ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Arcellx to present positive data on multiple myeloma treatments - 8 days ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 9 days ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 21 days ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 7 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - 11 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - 11 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 9 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago How a Multi-Cancer Screening Test Would Play Out in the Clinic - about 1 year ago
6	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Oncimmune announces new contract with global pharma company - 3 months ago
7	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 11 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago Emerging Biomarkers of Multiple Sclerosis in Blood and CSF - about 1 year ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 7 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago
9	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: WHO scientists question Grail’s plan for evaluating its multi-cancer Galleri blood test - 7 months ago
10	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 8 months ago

Journalists covering Multiple Myeloma,monoclonal gammopathy of undetermined significance,hematology,bone marrow